Astellas Pharma Inc. announced that Tomokazu Fujisawa and Hiroko Sakai to retire as Director, Audit & Supervisory Committee Member and Noriyuki Uematsu to retire as Outside Director, Audit & Supervisory Committee Member. at other organizations pursuant to the Companies Act. Mr. Raita Takahashi was elected as a substitute Director who is an Audit & Supervisory Committee Member at the 14th Term Annual Shareholders Meeting on June 18, 2019, but will resign from the substitute Director who is an Audit & Supervisory Committee Member at the start of the 15th Term Annual Shareholders Meeting.